Table 1.

Demographic and disease characteristics of patients included in our study

Characteristic	Percentage/Mean (Standard Deviation)
Male	61%
Age	49.2 (11.1)
BMI	27.4 (5.5)
Duration of PsA in years	11.3 (10)
Duration of psoriasis in years	18.4 (14.1)
Number of tender joints	1.7 (range 0–10)
Number of swollen joints	2.09 (range 0–10)
Pain	2.8 (2.8)
Fatigue	3.3 (3.3)
HAQ	0.45 (0.55)
DAS28-CRP	2.72 (1.28)
CDAI	9.1 (9.6)
SDAI	10.84 (10.25)
Enthesitis	19.5%
Body surface affected by psoriasis (BSA)	7.3 (range 0–95)
Treatment with TNF inhibitors	56%
Diabetes Mellitus type 2	17%
High Blood Pressure	44%
Dyslipidemia	29.2%